XNCR
Xencor, Inc.
NASDAQ · Healthcare · Biotechnology · US
$26.61
−0.04%Aug 5, 2026, 00:00 UTC
Xencor Inc reported Q2 2026 total revenue of $51.2 million, a 17.4% increase year-over-year, with a net loss of $21.7 million and diluted EPS of -$0.29.
Source: